Jennifer Martin

Research interests

Publications

• Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies

  Cell · 2020 · 10.1016/j.cell.2020.02.019

• A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury

  Gastroenterology · 2019 · https://doi.org/10.1053/j.gastro.2019.01.034

• A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects

  European Archives of Psychiatry and Clinical Neuroscience · 2019 · https://doi.org/10.1007/s00406-019-00978-2

• Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial

  Cannabis and Cannabinoid Research · 2018 · https://doi.org/10.1089/can.2017.0043

• Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects

  British Journal of Clinical Pharmacology · 2018 · https://doi.org/10.1111/bcp.13695

• The role of the GP in follow-up cancer care: a systematic literature review

  Journal of Cancer Survivorship · 2016 · https://doi.org/10.1007/s11764-016-0545-4

• Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study

  Gastroenterology · 2016 · 10.1053/j.gastro.2016.12.016

• Reducing Inappropriate Polypharmacy

  JAMA Internal Medicine · 2015 · https://doi.org/10.1001/jamainternmed.2015.0324

• The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’

  Supportive Care in Cancer · 2014 · https://doi.org/10.1007/s00520-014-2322-0

• Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

  Clinical Gastroenterology and Hepatology · 2014 · 10.1016/j.cgh.2014.02.024

• Minimizing Inappropriate Medications in Older Populations: A 10-step Conceptual Framework

  The American Journal of Medicine · 2012 · https://doi.org/10.1016/j.amjmed.2011.09.021

• Deciding when to stop: towards evidence-based deprescribing of drugs in older populations

  BMJ Evidence-Based Medicine · 2012 · https://doi.org/10.1136/eb-2012-100930

• Resveratrol – pills to replace a healthy diet?

  British Journal of Clinical Pharmacology · 2011 · https://doi.org/10.1111/j.1365-2125.2011.03966.x

• Association of Imaging Markers of Myocardial Fibrosis With Metabolic and Functional Disturbances in Early Diabetic Cardiomyopathy

  Circulation Cardiovascular Imaging · 2011 · https://doi.org/10.1161/circimaging.111.963587

• Therapeutic drug monitoring of antimicrobials

  British Journal of Clinical Pharmacology · 2011 · 10.1111/j.1365-2125.2011.04080.x

• Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

  Breast Cancer Research and Treatment · 2010 · https://doi.org/10.1007/s10549-010-0990-0

• Assessment of Nonischemic Myocardial Fibrosis

  Journal of the American College of Cardiology · 2010 · 10.1016/j.jacc.2010.02.047

• Marked increase in proton pump inhibitors use in Australia

  Pharmacoepidemiology and Drug Safety · 2010 · https://doi.org/10.1002/pds.1969

• Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia

  Vaccine · 2004 · https://doi.org/10.1016/j.vaccine.2004.05.013

• Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats

  Diabetes · 2003 · 10.2337/diabetes.52.3.741

• Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing

  The Journal of Immunology · 1993 · https://doi.org/10.4049/jimmunol.150.8.3478

Current projects

No projects listed.